Projects
Search from 1157 projects:
1157 Project(s)
SWISS TAVI
Nov 4, 2024Prospective, National, Multi-Center Registry of Patients Undergoing Transcatheter Aortic Valve Implantation (TAVI) in Switzerland (SwissTAVI)
Register - Nov 4, 2024 - Dec 30, 2040
Ongoing
Members: Haager Philipp, Vetsch Susanne, Maeder Micha
Colchicine in Patients at Cardiac Risk undergoing Major Non-Cardiac Surgery: prospective, randomized, triple-blinded, placebo-controlled, multi-centre study
Nov 1, 2024
Clinical Studies - Nov 1, 2024 - Sep 30, 2027
Scheduled
Project leader: Filipovic Miodrag, Yurttas Timur
Members: Klein Carsten, Keller Mirja
AMG 355 20220028
Oct 17, 2024Eine Phase-1-Studie am Menschen zur Bewertung der Sicherheit, Verträglichkeit, Pharmakokinetik und Wirksamkeit von AMG 355 als Monotherapie und in Kombination mit Pembrolizumab bei Patienten mit fortgeschrittenen soliden Tumoren
Clinical Studies - Oct 17, 2024 - Dec 31, 2028
Ongoing
Project leader: Jörger Markus
Members: Donno Monica, Müller Fiona
A comparison between the Swiss traffic perimetry (Swiss TPT) and the normal G2 strategy in automated perimetry: Observational cohort study
Oct 10, 2024Current Swiss visual requirements for driving are under re-evaluation. The present study aims to optimize visual field evaluation in daily practice to better differentiate between people who are fit to drive and those who are not.
Clinical Studies - Oct 10, 2024 - Oct 31, 2026
Ongoing
Project leader: Todorova Margarita
A multicenter, open-label, randomized, phase 2 study of venetoclax and azacitidine plus cusatuzumab versus venetoclax and azacitidine alone in newly diagnosed AML patients who are not candidates for intensive therapy
Oct 7, 2024
Clinical Studies - Oct 7, 2024 - Oct 9, 2028
Ongoing
Project leader: Schittenhelm Marcus
Members: Dei Cas Alissa
A phase 3 randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy and safety of Amyloid Depleter ALXN2220 in adult participants with Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
Oct 1, 2024
Clinical Studies - Oct 1, 2024 - Dec 31, 2029
Scheduled
Project leader: Ehl Niklas
Members: Vetsch Susanne
MS201924_0002
Sep 30, 2024An open-label, multicenter, randomized Phase 2 study of the ATR inhibitor tuvusertib in combination with the PARP inhibitor niraparib or the ATM inhibitor lartesertib in participants with BRCA mutant and/or homologous recombination deficiency (HRD) p...
Clinical Studies - Sep 30, 2024 - Sep 30, 2028
Ongoing
Project leader: Huober Jens
Members: Dei Cas Alissa, Müller Fiona
Humoral immunity and risk factors for Alongshan-virus in healthcare workers from Eastern Switzerland –proposal for a seroepidemiologic analysis
Aug 1, 2024In dieser prospektiven Studie innerhalb der SURPRISE+ Kohorte möchten wir die Seroprävalenz und Serokonversion gegen das Alongshan-Virus (ALSV). ALSV ist ein Flavivirus, welches ein FSME-ähnliches Krankheitsbild auslösen kann. Das Virus wird häufig i...
Clinical Studies - Aug 1, 2024 - Feb 28, 2026
Ongoing
Project leader: Kohler Philipp
Members: Frischknecht Manuel, Kuster Stefan, Kahlert Christian
Textile ECG electrodes for long-term monitoring (Tex3CG)
Jul 1, 2024The objective of this project is to evaluate and compare the signal quality of electrocardiogram (ECG) signals acquired by adhesive textile ECG electrodes (Tex) using adhesive gel electrodes (Gel) as a reference system.
Clinical Studies - Jul 1, 2024 - Dec 31, 2024
Ongoing
Project leader: Annaheim Simon, Ammann Peter
Members: Meier Jessica
Hemodynamic characteristics of bendopnea – pathophysiological basis of a novel symptom in heart failure patients
Jul 1, 2024The present project has several objectives. Our main goal is to evaluate the hemodynamic characteristics in particular the mean pulmonary artery wedge pressure (mPAWP) of patients with versus without bendopnea and those with high (supramedian) vers...
Clinical Studies - Jul 1, 2024 - Jun 30, 2026
Ongoing
Project leader: Maeder Micha
Members: Schneider Irene
Influence of COVID-19 Pandemic on the Incidence of Acute Otitis Media with Complications: A Retrospective Cohort Study at a Tertiary Care Hospital
Jul 1, 2024Acute otitis media (AOM) is typically a condition that resolves without long-term sequelae. However, it may be associated with complications. These can range from local complications such as involvement of the inner ear, potentially leading to persis...
Clinical Studies - Jul 1, 2024 - Jul 1, 2025
Ongoing
Project leader: Stöckli Sandro
Members: Albrich Werner, Menegotto Richard
A first-in-human, open-label, multicenter Phase l/ll study to evaluate the safety and anti-tumor activity of ANV600 as single agent and in combination with pembrolizumab in participants with advanced solid tumors (EXPAND-1)
Jun 13, 2024
Clinical Studies - Jun 13, 2024 - Dec 31, 2028
Ongoing
Project leader: Jörger Markus
Members: Sennhauser Andrina, Müller Fiona
Shunt-dependency after aneurysmal subarachnoid haemorrhage – the role of early hyperglycaemia in cerebro-spinal fluid and blood
May 26, 2024Several factors influence morbidity after aneurysmal subarachnoid haemorrhage (aSAH) and therefore also functional outcome. One of these factors is hydrocephalus (HCP) which, in case of unsuccessful weaning from an extraventricular drain (EVD) can le...
Clinical Studies - May 26, 2024 - Sep 1, 2027
Ongoing
Project leader: Hostettler Isabel
Members: Wiebe Lauren, Pietsch Urs, Klein Carsten, Keller Mirja, Kälin Vincens, Yildiz Yesim
FANTOM
May 6, 2024To evaluate the continued safety and performance of the Reva Fantom Sirolismus-Eluting Bioresorbable Coronary Scaffold in nativ coronary arteries that includes incorporation of a deformable expansion technologgy and an enhanced scaffold material (Tyr...
Clinical Studies - May 6, 2024 - Jun 30, 2030
Ongoing
Project leader: Rigger Johannes
Members: Fink Karin, Schneider Irene
Novel screening assay for novel psychoactive substances
May 1, 2024Consumption of so-called novel psychoactive substances (e.g. “synthetic opioids” and “synthetic cannabinoids”) is a growing global health threat. Due to the rapid market dynamics of the new drugs of abuse market current analytical methods cannot keep...
Fundamental Research - May 1, 2024 - Apr 30, 2025
Scheduled
Project leader: Moosmann Björn
Point Prevalence of Antibiotic Resistance in Helicobacter pylori in St. Gallen: An Observational Pilot Trial
May 1, 2024Evaluation der Antibiotika-Resistenz von Helicobacter pylori Magen und Überprüfung der Konsistenz von Resistenzdaten aus dem Stuhl und aus Magenbiopsien
Clinical Studies - May 1, 2024 - Jun 30, 2025
Scheduled
Project leader: Kueres-Wiese Alexander
Members: Kuster Stefan, Frei Nicola Fabian, Borovicka Jan
A PHASE 3, OPEN-LABEL, RANDOMIZED STUDY TO COMPARE THE EFFICACY AND SAFETY OF ODRONEXTAMAB (REGN1979), AN ANTICD20 X ANTI-CD3 BISPECIFIC ANTIBODY, VERSUS INVESTIGATOR’S CHOICE IN PREVIOUSLY UNTREATED PARTICIPANTS WITH FOLLICULAR LYMPHOMA (OLYMPIA-1)
Apr 18, 2024
Clinical Studies - Apr 18, 2024 - Dec 31, 2028
Completed
Project leader: Hitz Felicitas
Members: Bürki Ramona, Quinter Janine
A randomized, open-label Phase II/III efficacy and safety study of atezolizumab in combination with FLOT versus FLOT alone in patients with gastric cancer and adenocarcinoma of the oesophago-gastric junction and high immune responsiveness (MO30039/MO43340)– The DANTE Trial A Trial of AIO in collaboration with SAKK
Apr 17, 2024
Clinical Studies - Apr 17, 2024 - Dec 31, 2028
Ongoing
Project leader: Weisshaupt Christian
Members: Müller Fiona, Kehl Jeanine
Drainageflüssigkeitssensor zur Früherkennung von Anastomosenlecks
Apr 3, 2024Die Studie hat zum Ziel, Eigenschaften von abdominaler Drainageflüssigkeit von Patientinnen/Patienten, die sich einer Pankreas-, Ösophagus- oder Rektumoperation unterzogen haben, zu charakterisieren. In einem Folgeschritt soll die Korrelation einer S...
Clinical Studies - Apr 3, 2024 - Mar 31, 2025
Ongoing
Project leader: Tarantino Ignazio
Members: Seiler Edith, Matzinger Marlene
Analysis and outcomes of lacrimal pathway surgery
Apr 1, 2024Retrospective analysis of the outcome in patients operated on lacrimal pathway pathologies from 2016 onwards
Clinical Studies - Apr 1, 2024 - Dec 31, 2026
Ongoing
Project leader: Varde Meghana